Insider Transactions in Q3 2021 at Kymera Therapeutics, Inc. (KYMR)
Insider Transaction List (Q3 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 03
2021
|
Bruce N. Jacobs Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-33.19%
|
$600,000
$60.28 P/Share
|
Sep 03
2021
|
Bruce N. Jacobs Chief Financial Officer |
SELL
Exercise of conversion of derivative security
|
Direct |
10,000
-36.69%
|
$20,000
$2.08 P/Share
|
Aug 27
2021
|
Richard Chesworth Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
33,779
-100.0%
|
$2,026,740
$60.12 P/Share
|
Aug 27
2021
|
Richard Chesworth Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,779
+50.0%
|
$675,580
$20.0 P/Share
|
Aug 19
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+2.52%
|
$24,000
$2.08 P/Share
|
Aug 17
2021
|
Richard Chesworth Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
54,000
-75.06%
|
$2,754,000
$51.01 P/Share
|
Aug 17
2021
|
Richard Chesworth Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
54,000
+50.0%
|
$1,080,000
$20.0 P/Share
|
Aug 11
2021
|
Atlas Venture Associates X, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
242,133
-100.0%
|
$14,770,113
$61.0 P/Share
|
Aug 11
2021
|
Bruce Booth |
SELL
Open market or private sale
|
Indirect |
242,133
-100.0%
|
$14,770,113
$61.0 P/Share
|
Aug 04
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,037
-0.23%
|
$62,220
$60.03 P/Share
|
Aug 04
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,037
+0.23%
|
$2,074
$2.08 P/Share
|
Aug 03
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,669
-1.24%
|
$340,140
$60.07 P/Share
|
Aug 03
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,669
+1.22%
|
$11,338
$2.08 P/Share
|
Aug 02
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
23,456
-1.65%
|
$1,430,816
$61.23 P/Share
|
Aug 02
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,456
+4.7%
|
$46,912
$2.08 P/Share
|
Jul 30
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,279
-1.37%
|
$376,740
$60.07 P/Share
|
Jul 30
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,279
+1.35%
|
$12,558
$2.08 P/Share
|
Jul 29
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
680
-0.15%
|
$40,800
$60.0 P/Share
|
Jul 29
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
680
+0.15%
|
$1,360
$2.08 P/Share
|
Jul 28
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,864
-0.85%
|
$231,840
$60.15 P/Share
|
Jul 28
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,864
+0.84%
|
$7,728
$2.08 P/Share
|
Jul 26
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,015
-1.95%
|
$540,900
$60.15 P/Share
|
Jul 26
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,015
+1.92%
|
$18,030
$2.08 P/Share
|
Jul 08
2021
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
48,000
-2.47%
|
$2,400,000
$50.37 P/Share
|
Jul 08
2021
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
48,000
+8.76%
|
$96,000
$2.08 P/Share
|
Jul 01
2021
|
Bvf Partners L P Director |
BUY
Open market or private purchase
|
Direct |
544,166
+13.94%
|
$25,575,802
$47.0 P/Share
|